Patna: The All India Institute of Medical Sciences, Patna, is expected to start human trials of COVAXIN, the coronavirus vaccine, this week.
The report said AIIMS-Patna is among the 12 medical institutes selected by the Indian Council for Medical Research (ICMR). The vaccine is derived from a strain of SARS-CoV-2.
AIIMS-Patna Superintendant Dr CM Singh said that the clinical trials of the country’s first indigenous COVID-19 vaccine would start in the next two days.
He said that the clinical vaccine trials will be initially carried out on 100 people registered for the purpose.